Correlation Between Lipella Pharmaceuticals and VanEck Morningstar
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and VanEck Morningstar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and VanEck Morningstar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and VanEck Morningstar Durable, you can compare the effects of market volatilities on Lipella Pharmaceuticals and VanEck Morningstar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of VanEck Morningstar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and VanEck Morningstar.
Diversification Opportunities for Lipella Pharmaceuticals and VanEck Morningstar
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Lipella and VanEck is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and VanEck Morningstar Durable in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Morningstar and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with VanEck Morningstar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Morningstar has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and VanEck Morningstar go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and VanEck Morningstar
Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 12.18 times more return on investment than VanEck Morningstar. However, Lipella Pharmaceuticals is 12.18 times more volatile than VanEck Morningstar Durable. It trades about -0.01 of its potential returns per unit of risk. VanEck Morningstar Durable is currently generating about -0.23 per unit of risk. If you would invest 321.00 in Lipella Pharmaceuticals Common on September 12, 2024 and sell it today you would lose (19.00) from holding Lipella Pharmaceuticals Common or give up 5.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. VanEck Morningstar Durable
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| VanEck Morningstar |
Lipella Pharmaceuticals and VanEck Morningstar Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and VanEck Morningstar
The main advantage of trading using opposite Lipella Pharmaceuticals and VanEck Morningstar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, VanEck Morningstar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Morningstar will offset losses from the drop in VanEck Morningstar's long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| VanEck Morningstar vs. Davis Select Equity | VanEck Morningstar vs. Entia Biosciences | VanEck Morningstar vs. Lipella Pharmaceuticals Common | VanEck Morningstar vs. Centor Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |